Cargando…

The clinicopathological characteristics and prognosis of young patients with chondrosarcoma of bone

PURPOSE: Clinicopathologic characteristics and treatment outcomes for young patients (less than 40 years) with chondrosarcoma of bone are rarely documented. The purpose of this study is to determine the clinicopathological characteristics and identify the survival predictors for this rare population...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Tao, Sun, Yuanyuan, Han, Xiao, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484535/
https://www.ncbi.nlm.nih.gov/pubmed/36132200
http://dx.doi.org/10.3389/fsurg.2022.926008
_version_ 1784791895948394496
author Xie, Tao
Sun, Yuanyuan
Han, Xiao
Zhang, Jian
author_facet Xie, Tao
Sun, Yuanyuan
Han, Xiao
Zhang, Jian
author_sort Xie, Tao
collection PubMed
description PURPOSE: Clinicopathologic characteristics and treatment outcomes for young patients (less than 40 years) with chondrosarcoma of bone are rarely documented. The purpose of this study is to determine the clinicopathological characteristics and identify the survival predictors for this rare population. PATIENTS AND METHODS: We used the Surveillance, Epidemiology, and End Results (SEER) database to identify young patients with chondrosarcoma of bone between 1973 and 2016. Univariate and multivariate Cox regression analyses were conducted to determine the independent risk factors. Kaplan-Meier method was used to intuitively show the survival difference stratified by different treatments. RESULTS: A total of 1312 eligible young patients with chondrosarcoma of bone were analyzed this study. The mean age at diagnosis was 28.5 ± 0.2 years old (ranging from 1 to 40 years). 51.1% of cases were located in the extremity. More than two-thirds of patients (71.4%) were high grade. The majority of the patients (92.0%) received surgery, only 11.8% of patients received radiotherapy, and only 10.4% of patients received chemotherapy. The 5-year overall survival (OS) and cancer-specific survival (CSS) rates of this cohort were 88.5% and 89.1%, respectively. According to the results of multivariate analysis, nine variables were significantly correlated with OS and CSS, including gender, year of diagnosis, tumor site, tumor grade, tumor subtype, distant metastasis, tumor size, surgery, and chemotherapy. CONCLUSION: Young patients with chondrosarcoma of bone experienced better prognosis. Surgery was significantly correlated with increased survival, while chemotherapy was significantly correlated with decreased survival. Radiotherapy was not a meaningful survival predictor of young patients with chondrosarcoma of bone. Prospective clinical trials are needed in the future to determine the effect of radiotherapy and chemotherapy on prognosis of those patients.
format Online
Article
Text
id pubmed-9484535
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94845352022-09-20 The clinicopathological characteristics and prognosis of young patients with chondrosarcoma of bone Xie, Tao Sun, Yuanyuan Han, Xiao Zhang, Jian Front Surg Surgery PURPOSE: Clinicopathologic characteristics and treatment outcomes for young patients (less than 40 years) with chondrosarcoma of bone are rarely documented. The purpose of this study is to determine the clinicopathological characteristics and identify the survival predictors for this rare population. PATIENTS AND METHODS: We used the Surveillance, Epidemiology, and End Results (SEER) database to identify young patients with chondrosarcoma of bone between 1973 and 2016. Univariate and multivariate Cox regression analyses were conducted to determine the independent risk factors. Kaplan-Meier method was used to intuitively show the survival difference stratified by different treatments. RESULTS: A total of 1312 eligible young patients with chondrosarcoma of bone were analyzed this study. The mean age at diagnosis was 28.5 ± 0.2 years old (ranging from 1 to 40 years). 51.1% of cases were located in the extremity. More than two-thirds of patients (71.4%) were high grade. The majority of the patients (92.0%) received surgery, only 11.8% of patients received radiotherapy, and only 10.4% of patients received chemotherapy. The 5-year overall survival (OS) and cancer-specific survival (CSS) rates of this cohort were 88.5% and 89.1%, respectively. According to the results of multivariate analysis, nine variables were significantly correlated with OS and CSS, including gender, year of diagnosis, tumor site, tumor grade, tumor subtype, distant metastasis, tumor size, surgery, and chemotherapy. CONCLUSION: Young patients with chondrosarcoma of bone experienced better prognosis. Surgery was significantly correlated with increased survival, while chemotherapy was significantly correlated with decreased survival. Radiotherapy was not a meaningful survival predictor of young patients with chondrosarcoma of bone. Prospective clinical trials are needed in the future to determine the effect of radiotherapy and chemotherapy on prognosis of those patients. Frontiers Media S.A. 2022-09-05 /pmc/articles/PMC9484535/ /pubmed/36132200 http://dx.doi.org/10.3389/fsurg.2022.926008 Text en © 2022 Xie, Sun, Han and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Surgery
Xie, Tao
Sun, Yuanyuan
Han, Xiao
Zhang, Jian
The clinicopathological characteristics and prognosis of young patients with chondrosarcoma of bone
title The clinicopathological characteristics and prognosis of young patients with chondrosarcoma of bone
title_full The clinicopathological characteristics and prognosis of young patients with chondrosarcoma of bone
title_fullStr The clinicopathological characteristics and prognosis of young patients with chondrosarcoma of bone
title_full_unstemmed The clinicopathological characteristics and prognosis of young patients with chondrosarcoma of bone
title_short The clinicopathological characteristics and prognosis of young patients with chondrosarcoma of bone
title_sort clinicopathological characteristics and prognosis of young patients with chondrosarcoma of bone
topic Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484535/
https://www.ncbi.nlm.nih.gov/pubmed/36132200
http://dx.doi.org/10.3389/fsurg.2022.926008
work_keys_str_mv AT xietao theclinicopathologicalcharacteristicsandprognosisofyoungpatientswithchondrosarcomaofbone
AT sunyuanyuan theclinicopathologicalcharacteristicsandprognosisofyoungpatientswithchondrosarcomaofbone
AT hanxiao theclinicopathologicalcharacteristicsandprognosisofyoungpatientswithchondrosarcomaofbone
AT zhangjian theclinicopathologicalcharacteristicsandprognosisofyoungpatientswithchondrosarcomaofbone
AT xietao clinicopathologicalcharacteristicsandprognosisofyoungpatientswithchondrosarcomaofbone
AT sunyuanyuan clinicopathologicalcharacteristicsandprognosisofyoungpatientswithchondrosarcomaofbone
AT hanxiao clinicopathologicalcharacteristicsandprognosisofyoungpatientswithchondrosarcomaofbone
AT zhangjian clinicopathologicalcharacteristicsandprognosisofyoungpatientswithchondrosarcomaofbone